menu
    • menu
    [{"orgOrder":0,"company":"AiPing Pharmaceutical Inc","sponsor":"ECI Pharmaceuticals LLC","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"U.S.A","productType":"Small molecule","year":"2021","type":"Agreement","leadProduct":"Ibuprofen","moa":"COX","graph1":"Neurology","graph2":"Approved","graph3":"AiPing Pharmaceutical Inc","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Inhalation","sponsorNew":"AiPing Pharmaceutical Inc \/ ECI Pharmaceuticals LLC","highestDevelopmentStatusID":"12","companyTruncated":"AiPing Pharmaceutical Inc \/ ECI Pharmaceuticals LLC"}]

    Find Clinical Drug Pipeline Developments & Deals by AiPing Pharmaceutical Inc

    Menu

    AiPing Pharmaceutical Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    AiPing Pharmaceutical Inc

    U.S.A arrow
    ICHH-25
    Not Confirmed

    AiPing Pharmaceutical Inc

    U.S.A arrow
    ICHH-25
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Ibuprofen

    Therapeutic Area : Neurology

    Study Phase : Approved

    Sponsor : ECI Pharmaceuticals LLC

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen

    Details : According to IQVIA data for the 12 months ended December 2020, total U.S. generic sales of Ibuprofen tablets 400 mg, 600 mg, 800 mg was approximately $110 million. Generic Folic Acid tablets 1 mg were approximately $20 million for the same period.

    Product Name : Ibuprofen-Generic

    Product Type : Small molecule

    Upfront Cash : Undisclosed

    April 23, 2021

    Lead Product(s) : Ibuprofen

    Therapeutic Area : Neurology

    Highest Development Status : Approved

    Sponsor : ECI Pharmaceuticals LLC

    Deal Size : Undisclosed

    Deal Type : Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth